Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation

This publication has 16 references indexed in Scilit:

• Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling
  Science Translational Medicine, 2011
• An early event of EGFR mutation in pleomorphic carcinoma of the lung
  International Journal of Clinical Oncology, 2011
• Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
  Clinical Cancer Research, 2011
• A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
  Cell, 2010
• Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
  New England Journal of Medicine, 2009
• Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
  New England Journal of Medicine, 2008
• The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
  Proceedings of the National Academy of Sciences, 2008
• Presence ofEpidermal Growth Factor ReceptorGene T790M Mutation as a Minor Clone in Non–Small Cell Lung Cancer
  Cancer Research, 2006
• EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2005
• Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer
  Cancer Research, 2004